
Recently at the Saha Group Fair, Saha Group partnered with Quark Biosciences to jointly enter the biotechnology industry, signing a memorandum of understanding (MOU) at the 28th Saha Group Fair held at BITEC Bangna on 27 June 2024. Ms Supamas Isarabhakdi, Minister of Higher Education, Science, Research, and Innovation of Thailand, presided over and served as an honorary witness at the signing ceremony. Additionally, Professor Dr Piyamitr Sritara, Chairman of the Executive Board, The National Center for Genetic Engineering and Biotechnology (BIOTEC), was honoured to join as an honorary witness at this MOU signing ceremony.
Ms Supamas Isarabhakdi stated, “As Thai society steps into an ageing society, having good healthcare is essential for building a strong foundation. Rapid technological change affects innovation that can enhance healthcare and beauty technologies to be more efficient, precise, and safe. This is considered a new wave in the health and beauty industry.”
Mr Boonsithi Chokwatana, Chairman of SAHA Group, highlighted, “This MOU signing ceremony marks a good start between SAHA Group and Quark Biosciences Inc., experts in innovative medical technology from Taiwan. This collaboration is the beginning of elevating the future of the health and beauty industry for Thailand’s ageing population. It aims to develop high-quality products for the market and run a sustainable business. Moreover, it is a significant step in shaping the future of Thailand’s health and beauty industry.”
Dr Johnsee Lee, Chairman of Quark Biosciences, expressed enthusiasm for partnering with Saha Group, aiming to bring state-of-the-art technologies to Thailand. He pledged to utilise the MOU as a blueprint to collaborate actively with local experts and scholars in launching the best products and technologies tailored to meet local needs.
“Quark Biosciences' exclusive NextAmp™ platform, a multi-gene analysis system combining expertise in electronics, semiconductors, biology, and chemistry, allows rapid, accurate, and convenient quantitative analysis of up to 100 genes within two hours at an affordable cost. This technology, akin to a capsule coffee machine in simplicity, has been applied to early cancer detection, infectious diseases, reproductive health, and microbial genome testing. Additionally, the company offers health risk assessment and microbiome testing products, providing comprehensive analytical information and solutions through precise personal health and beauty AI applications for every user,” said Dr Johnsee Lee.
For additional information, media representatives are requested to contact: Public Relations Department, 28th Saha Group Fair. Integrated Communication, Co. Ltd., Tel: 0 2354 3588 www.incom.co.th Usanee Tavornkarn Tel: 081 984 5500 Email: usanee@incom.co.th


